Andrew James Mclean
Direktor/Vorstandsmitglied bei Macrophox Ltd.
Aktive Positionen von Andrew James Mclean
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Macrophox Ltd.
Macrophox Ltd. BiotechnologyHealth Technology Macrophox Ltd. engages in the provision of research and experimental development on biotechnology. The company was founded on March 12, 2018 and is headquartered in Woodstock, The United Kingdom. | Direktor/Vorstandsmitglied | 05.10.2018 | - |
Tin Alley Ventures
Tin Alley Ventures Investment ManagersFinance Tanarra Ventures Pty Ltd (Tanarra Ventures) is a venture capital firm subsidiary of Tanarra Group Pty Ltd founded in 2005 by John Wylie. The firm is headquartered in Melbourne, Australia. | Private Equity Investor | 01.03.2023 | - |
Karriereverlauf von Andrew James Mclean
Ehemalige bekannte Positionen von Andrew James Mclean
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Theolytics Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Oxford, the United Kingdom. | Direktor/Vorstandsmitglied | 01.12.2017 | 01.08.2020 |
Pepgen Ltd.
Pepgen Ltd. Packaged SoftwareTechnology Services Pepgen Ltd. engages in research and experimental development on biotechnology. The company was founded on January 25, 2018 and is headquartered in Oxford, the United Kingdom. | Direktor/Vorstandsmitglied | 26.03.2018 | 01.07.2020 |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Direktor/Vorstandsmitglied | 01.03.2016 | 01.06.2020 |
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Direktor/Vorstandsmitglied | 01.10.2018 | 01.12.2019 |
DJS Antibodies Ltd.
DJS Antibodies Ltd. BiotechnologyHealth Technology DJS Antibodies Ltd. designs and discovers novel therapeutic monoclonal antibodies against G-protein-coupled receptors. The firm conducts discovery against three targets in the fields of oncology, fibrosis and vascular disease. The company was founded by David Colin Conway Llewellyn and Joseph James Illingworth and is headquartered in Bicester, the United Kingdom. | Direktor/Vorstandsmitglied | 01.10.2016 | 01.12.2019 |
BARINTHUS BIOTHERAPEUTICS PLC | Direktor/Vorstandsmitglied | 01.01.2016 | 01.12.2019 |
Ausbildung von Andrew James Mclean
University of Oxford | Undergraduate Degree |
The University of Western Australia | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 9 |
Australien | 3 |
Operativ
Director/Board Member | 7 |
Undergraduate Degree | 2 |
Private Equity Investor | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
Private Unternehmen | 7 |
---|---|
Theolytics Ltd.
Theolytics Ltd. BiotechnologyHealth Technology Theolytics Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Oxford, the United Kingdom. | Health Technology |
Evox Therapeutics Ltd.
Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Health Technology |
DJS Antibodies Ltd.
DJS Antibodies Ltd. BiotechnologyHealth Technology DJS Antibodies Ltd. designs and discovers novel therapeutic monoclonal antibodies against G-protein-coupled receptors. The firm conducts discovery against three targets in the fields of oncology, fibrosis and vascular disease. The company was founded by David Colin Conway Llewellyn and Joseph James Illingworth and is headquartered in Bicester, the United Kingdom. | Health Technology |
Macrophox Ltd.
Macrophox Ltd. BiotechnologyHealth Technology Macrophox Ltd. engages in the provision of research and experimental development on biotechnology. The company was founded on March 12, 2018 and is headquartered in Woodstock, The United Kingdom. | Health Technology |
Pepgen Ltd.
Pepgen Ltd. Packaged SoftwareTechnology Services Pepgen Ltd. engages in research and experimental development on biotechnology. The company was founded on January 25, 2018 and is headquartered in Oxford, the United Kingdom. | Technology Services |
MiroBio Ltd.
MiroBio Ltd. BiotechnologyHealth Technology Mirobio Ltd. operates as a biologics company focusing on autoimmune and inflammatory disorders. The firm develops antibody modulators of immune cell receptors, an approach that has potential across a range of diseases, with an initial focus on auto-immune disease. The company was founded by Richard Cornall and Simon Davis on October 8, 2018 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Tin Alley Ventures
Tin Alley Ventures Investment ManagersFinance Tanarra Ventures Pty Ltd (Tanarra Ventures) is a venture capital firm subsidiary of Tanarra Group Pty Ltd founded in 2005 by John Wylie. The firm is headquartered in Melbourne, Australia. | Finance |
- Börse
- Insiders
- Andrew James Mclean
- Erfahrung